Concepedia

Author

J E Westlin

Uppsala University Hospital

Also Known As

J E Westlin, J Westlin, J-E Westlin, J. -E. Westlin, J. E. Westlin, J. Westlin, J.-E. Westlin, J.E. Westlin, Jan‐Erik Westlin

29

Publications

664

Citations

9

H-Index

24

Concepts

All Affiliations

Uppsala University Hospital
JE

About

J E Westlin is an author at Uppsala University Hospital specializing in oncology, medicine, and radiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

296

2

Pathology

3

3

200

3

Engineering

1

1

20

4

Health Sciences

1

1

59

5

Immunology

1

1

82

J E Westlin

×

9

Publications

622

Citations

9

H-Index

YearCitations

Positron emission tomography studies in patients with locally advanced and/or metastatic breast cancer: a method for early therapy evaluation?

T. Jansson, J E Westlin, Håkan Åhlström,

Journal of Clinical Oncology

1995

262

Treatment of Malignant Endocrine Pancreatic Tumors with a Combination of α-Interferon and Somatostatin Analogs

Marie-Louise Fjällskog, Anders Sundin, J E Westlin,

Medical Oncology

2002

82

Metastatic hormone-refractory prostatic adenocarcinoma expresses somatostatin receptors and is visualized in vivo by [111In]-labeled DTPA-D-[Phe1]-octreotide scintigraphy.

Sten Nilsson, Jean Claude Reubi, Karl Mikael Kälkner,

PubMed

1995

59

Somatostatin receptor scintigraphy in patients with carcinoid tumors: comparison between radioligand uptake and tumor markers.

Karl Mikael Kälkner, Eva Tiensuu Janson, Sten Nilsson,

PubMed

1995

59

Adjuvant intraperitoneal 5-fluorouracil and intravenous leucovorin after colorectal cancer surgery: a randomized phase II placebo-controlled study

W. Graf, J E Westlin, L. P�hlman,

International Journal of Colorectal Disease

1994

44

Scintigraphic assessment of slow transit constipation with special reference to right‐ or left‐sided colonic delay

Evelyn Serreyn Lundin, Urban Karlbom, J E Westlin,

Colorectal Disease

2004

36

Identification of sentinel nodes in patients with colon cancer

Kjell Dahl, J E Westlin, Wolfgang Kraaz,

European Journal of Surgical Oncology

2005

32

[ <sup>111</sup> In-DPTA-D-Phe <sup>1</sup> ] - Octreotide Scintigraphy in the Management of Patients with Advanced Renal Cell Carcinoma

M Edgren, J E Westlin, Karl Mikael Kälkner,

Cancer Biotherapy and Radiopharmaceuticals

1999

28

[111In-DTPA-D-Phe1]-octreotide scintigraphy in patients with hormone-refractory prostatic adenocarcinoma can predict therapy outcome with octreotide treatment: a pilot study.

Karl Mikael Kälkner, S. Nilsson, J E Westlin

PubMed

1998

20

Page 1